While the beneficial effects of H1R antagonists against allergic urticaria and rhinoconjunctivitis are undisputed, their positive influence on histamine-mediated anaphylactic shock and bronchoconstriction has not been demonstrated [12]. The gene discussed is HRH1; the disease is anaphylaxis.